A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111

Blood

Volumn 92, Issue 5, 1998, Pages 1556-1564

  Larson, Richard A ^a   Dodge, Richard K ^b   Linker, Charles A ^b   Stone, Richard M ^b   Powell, Bayard L ^b   Lee, Edward J ^b   Schulman, Philip ^b   Davey, Frederick R ^b   Frankel, Stanley R ^b   Bloomfield, Clara D ^b   George, Stephen L ^b   Schiffer, Charles A ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PLACEBO; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOUBLE-BLIND METHOD; FILGRASTIM; HUMANS; LENGTH OF STAY; LEUKEMIA, LYMPHOCYTIC, ACUTE; MIDDLE AGED; NEUTROPENIA; PLACEBOS; REMISSION INDUCTION; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 0032170428     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 85:2025, 1995
2. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the acute leukemias. French-American-British (FAB) Co-operative Group. Br J Haematol 33:451, 1976
3. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: The morphologic classification of acute lymphoblastic leukemia. Concordance among observers and clinical correlations. Br J Haematol 47:553, 1981
4. Weiss RB, Vogelzang NJ, Peterson BA, Panasci LC, Carpenter JT, Gavignan M, Sartell K, Frei E, McIntyre OR: A successful system for scientific data audits for clinical trials: A report for the Cancer and Leukemia Group B. JAMA 270:459, 1993
5. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
6. Armitage P: Statistical Methods in Medical Research. London, UK, Blackwell Scientific Publications, 1971
7. Simon R, Lee YJ: Nonparametric confidence limits for survival probabilities and median survival time. Cancer Treat Rep 66:37, 1982
8. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
9. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, NY, Wiley, 1989
10. Cox DR: Regression models and life tables. J R Stat Soc B 34:187, 1972
11. Weite K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88:1907, 1996
12. Pui C-H, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T, Relling MV, Ribeiro RC, Crist WM, Evans WE: Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med 336:1781, 1997
13. Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G: Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: A randomized phase III trial. Blood 86:444, 1995
14. Tsuchiya H, Adachi N, Asou N, Takatsuki K, Matsuda I, Kawano F, Murakami T, Mizutani S, Watanabe M: Responses to granulocyte colony-stimulating factor and granulocyte-macrophage CSF in Ph-positive acute lymphoblastic leukemia with myeloid surface markers. Blood 77:411, 1991
15. Jenkins CSP, Ozer H, Parker JC: Mobilization of CALLA-positive lymphoblasts during treatment with granulocyte colony-stimulating factor. Blood 80:2944, 1992
16. Laport GF, Larson RA: Treatment of adult acute lymphoblastic leukemia. Sem Oncol 24:70, 1997
17. Smith TJ, Herndon JE, Larson RA, Schiffer CA, McDonald K, Penberthy L, Weeks JA: Measuring costs and clinical outcomes from prospective clinical trial and retrospective financial databases: Experience gained from Cancer and Leukemia Group B study 9411. Proc Am Soc Clin Oncol 16:420a, 1997 (abstr 1502)